Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125726251 | 12572625 | 1 | I | 20160706 | 20160720 | 20160720 | EXP | CA-JNJFOC-20160710558 | JOHNSON AND JOHNSON | 86.00 | YR | E | F | Y | 51.00000 | KG | 20160720 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125726251 | 12572625 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | U | U | 19872 | UNSPECIFIED | ||||||||
| 125726251 | 12572625 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 25 DAY(S) | U | U | 19872 | 650 | MG | UNSPECIFIED | QID | ||||
| 125726251 | 12572625 | 3 | C | AMPICILLIN | AMPICILLIN | 1 | Intravenous (not otherwise specified) | 0 | UNSPECIFIED | ||||||||||
| 125726251 | 12572625 | 4 | C | FLEET ENEMA | SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, MONOBASIC | 1 | Unknown | 0 | ENEMA | ||||||||||
| 125726251 | 12572625 | 5 | C | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Subcutaneous | 0 | INTRAVENOUS INFUSION | ||||||||||
| 125726251 | 12572625 | 6 | C | K-DUR | POTASSIUM CHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125726251 | 12572625 | 7 | C | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125726251 | 12572625 | 8 | C | ZYPREXA | OLANZAPINE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125726251 | 12572625 | 9 | C | OXYCODONE | OXYCODONE | 1 | Oral | 0 | TABLET | ||||||||||
| 125726251 | 12572625 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125726251 | 12572625 | 11 | C | LACTULOSE SYRUP | 2 | Oral | 0 | LIQUID | |||||||||||
| 125726251 | 12572625 | 12 | C | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125726251 | 12572625 | 13 | C | SUPPOSITOIRES A LA GLYCERINE | 2 | Unknown | 0 | SUPPOSITORY |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125726251 | 12572625 | 2 | Product used for unknown indication |
| 125726251 | 12572625 | 3 | Product used for unknown indication |
| 125726251 | 12572625 | 4 | Product used for unknown indication |
| 125726251 | 12572625 | 5 | Product used for unknown indication |
| 125726251 | 12572625 | 6 | Product used for unknown indication |
| 125726251 | 12572625 | 7 | Product used for unknown indication |
| 125726251 | 12572625 | 8 | Product used for unknown indication |
| 125726251 | 12572625 | 9 | Product used for unknown indication |
| 125726251 | 12572625 | 10 | Product used for unknown indication |
| 125726251 | 12572625 | 11 | Product used for unknown indication |
| 125726251 | 12572625 | 12 | Product used for unknown indication |
| 125726251 | 12572625 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125726251 | 12572625 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125726251 | 12572625 | Alanine aminotransferase increased | |
| 125726251 | 12572625 | Aspartate aminotransferase increased | |
| 125726251 | 12572625 | Blood alkaline phosphatase increased | |
| 125726251 | 12572625 | Blood bilirubin increased | |
| 125726251 | 12572625 | Gamma-glutamyltransferase increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |